AAP: Recommendations for COVID-19 Vaccines
On August 19, the American Academy of Pediatrics Committee on Infectious Diseases provided the following recommendations for Infants, Children, and Adolescents and COVID-19 Vaccines. [See policy statement.] Infants and children 6-23 months of age who do not have contraindications should receive 2025-2026 COVID-19 vaccine Children 6 months – 18 years of age who are moderately or severely immunocompromised require 2+ doses of age-appropriate 2025-2026 COVID-19 vaccine depending on previous vaccination status A single dose of age-appropriate 2025-2026 COVID-19 vaccine is recommended for all children and adolescents 2-18 years in the following high risk groups (regardless of prior COVID-19 vaccination status) Read More …
